Levosimendan freeze-dried preparation and preparing method
A technology of freeze-dried preparations and preparations, applied in the field of pharmaceutical preparations, can solve the problems of patient irritation, side effects, complex preparation process, etc., and achieve the effects of reducing related substances, facilitating transportation, good solubility and stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0025] Levosimendan 12.5mg
[0026] Mannitol 550mg
[0027] 0.2mol / L disodium hydrogen phosphate 2.5ml
[0028] 0.2mol / L sodium dihydrogen phosphate 0.23ml
[0029] Add water for injection to 5ml
[0030] Take levosimendan (synthesized according to the methods described in WO9212135 and GB2228004), mannitol, add disodium hydrogen phosphate and sodium dihydrogen phosphate solution, stir to completely dissolve (pH≈7.8), add 5 mg of activated carbon, and continue stirring for 30 min. Decarbonize, add water for injection to make up to 5ml, and sterilize by fine filtration with 0.22μm microporous membrane. Under aseptic conditions, the obtained solution is placed in a sterile vial, freeze-dried in a freeze dryer, and sealed. The yellow levosimendan freeze-dried powder preparation A of the present invention was obtained.
Embodiment 2
[0032] Levosimendan 12.5mg
[0033] Mannitol 280mg
[0034] Povidone 50mg
[0035] 0.2mol / L disodium hydrogen phosphate 1.46ml
[0036] 0.2mol / L sodium dihydrogen phosphate 0.14ml
[0037] Add water for injection to 3ml
[0038] Take levosimendan, povidone, and mannitol, add disodium hydrogen phosphate and sodium dihydrogen phosphate solution, stir to dissolve completely (pH≈7.8), add 3 mg of activated carbon, continue stirring for 30 minutes, decarbonize, add water for injection to set Make up to 3ml, sterilize by fine filtration with 0.22μm microporous membrane. Under aseptic conditions, the obtained solution is placed in a sterile vial, freeze-dried in a freeze dryer, and sealed. The yellow levosimendan freeze-dried powder preparation B of the present invention was obtained.
Embodiment 3
[0040] Levosimendan 12.5mg
[0041] Mannitol 190mg
[0042] Hydroxypropyl-β-cyclodextrin 136.8mg
[0043] 0.2mol / L disodium hydrogen phosphate 1.46ml
[0044] 0.2mol / L sodium dihydrogen phosphate 0.14ml
[0045] Add water for injection to 3ml
[0046] Take 12.5 mg of levosimendan, 2-hydroxypropyl-β-cyclodextrin, and mannitol, add disodium hydrogen phosphate and sodium dihydrogen phosphate solution, stir to dissolve completely (pH≈7.8), add 3 mg of activated carbon, continue Stir for 30 minutes, decarbonize, add water for injection to make up to 3ml, and sterilize by fine filtration with 0.22μm microporous membrane. Under aseptic conditions, the obtained solution is placed in a sterile vial, freeze-dried in a freeze dryer, and sealed. The yellow levosimendan freeze-dried powder preparation C of the present invention was obtained.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com